ReviewAmerican journal of epidemiology2019
Emerging Challenges and Opportunities in Infectious Disease Epidemiology.
Review in American journal of epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Artificial Intelligence in Infectious Disease Research.EcoHealth · 2026Article
- Global Genomic Surveillance: On-The-Ground Responses.Current topics in microbiology and immunology · 2026Review
- Clinical progression parameters associated with SARS-CoV-2, influenza, and respiratory syncytial virus infections in a large US integrated healthcare population.PLoS computational biology · 2025Article
- A Primer on Inference and Prediction With Epidemic Renewal Models and Sequential Monte Carlo.Statistics in medicine · 2025Article
- Comparative antibacterial activity of clove extract against Pseudomonas aeruginosa.BMC complementary medicine and therapies · 2025Article
- Debulking influenza and herpes simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum.Molecular therapy : the journal of the American Society of Gene Therapy · 2025Article
- Review
- Impact of National Immunization Strategies on Vaccine-Preventable Diseases - China, 1950-2021.China CDC weekly · 2024Article
- Identification of Early Warning Signals of Infectious Diseases in Hospitals by Integrating Clinical Treatment and Disease Prevention.Current medical science · 2024Article
- Zoonotic Parasites and Their Association With Human Activities in Northern Tanzania: An Integrated Ecosystem Approach for One Health.Journal of parasitology research · 2024Article
- Towards interoperability in infection control: a standard data model for microbiology.Scientific data · 2023Article
- How Effective are Metal Nanotherapeutic Platforms Against Bacterial Infections? A Comprehensive Review of Literature.International journal of nanomedicine · 2023Review
- Systems-Based Approach for Optimization of Assembly-Free Bacterial MLST Mapping.Life (Basel, Switzerland) · 2022Article
- Editorial: New omics research challenges for Public and sustainable Health.Frontiers in microbiology · 2022Article
- Metagenomic next-generation sequencing for the detection of pathogenic microorganisms in patients with pulmonary infection.American journal of translational research · 2022Article
- The influence of preventive strategies on the COVID-2019 epidemic in Shenzhen, China.The European respiratory journal · 2020Article
- Epidemiology: Back to the Future.American journal of epidemiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Much of the intellectual tradition of modern epidemiology stems from efforts to understand and combat chronic diseases persisting through the 20th century epidemiologic transition of countries such as the United States and United Kingdom. After decades of relative obscurity, infectious disease epidemiology has undergone an intellectual rebirth in recent years amid increasing recognition of the threat posed by both new and familiar pathogens. Here, we review the emerging coalescence of infectious disease epidemiology around a core set of study designs and statistical methods bearing little resemblance to the chronic disease epidemiology toolkit. We offer our outlook on challenges and opportunities facing the field, including the integration of novel molecular and digital information sources into disease surveillance, the assimilation of such data into models of pathogen spread, and the increasing contribution of models to public health practice. We next consider emerging paradigms in causal inference for infectious diseases, ranging from approaches to evaluating vaccines and antimicrobial therapies to the task of ascribing clinical syndromes to etiologic microorganisms, an age-old problem transformed by our increasing ability to characterize human-associated microbiota. These areas represent an increasingly important component of epidemiology training programs for future generations of researchers and practitioners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.